Evidence map›Paper›PMID 37643301›Full record

SynthesisCannabis and cannabinoid research2024

Pharmacokinetics of Cannabidiol: A Systematic Review and Meta-Regression Analysis.

Ehsan Moazen-Zadeh, Alexandra Chisholm, Keren Bachi, Yasmin L Hurd

Open access · greenAbstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Cannabis and cannabinoid research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Research and Clinical Practice Involving the Use ofPharmaceuticals (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ehsan Moazen-ZadehDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0003-0846-1402
Alexandra ChisholmDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Keren BachiDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Yasmin L HurdDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Mount Sinai Health System · US

Funding

Cannabidiol in the treatment of opioid use disorderUG3DA050323 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HURD, YASMIN L. · 2019 to 2019
$7.5M
Mentalizing deficits in cocaine addiction, associations with immune dysregulation and childhood maltreatmentK23DA045928 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BACHI, KEREN · 2018 to 2022
$649k
NIDA NIH HHS K23 DA045928NIDA NIH HHS UG3 DA050323
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabidiolAdministration, InhalationAdministration, OralFemaleHumansMaleRegression AnalysisCannabidiolbioavailabilitycannabisCBDclinical trialspharmacokinetics

Identifiers

PMID37643301
PMCPMC11397906
OpenAlexW4386249423

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.